Clinical Trial Update: Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting to evaluate intralesional metronidazole for cutaneous leishmaniasis. The study aims to assess effectiveness and safety of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Metronidazole (intralesional) (Metronidazole)

Snippet

Sponsor: Hayder Adnan Fawzi | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: RECRUITING